PE-conjugated Anti-CTLA-4 (ipilimumab biosimilar) mAb

Price: 100 test ￥1360.00

SKU: BME100022P Category: Biosimilar reference antibodies

Uniprot ID	P16410
Common Name	BMS-734016, MDX-010, MDX-CTLA-4
Synonyms	CTLA4;CD152
Applications	Flow Cyt
Recommended Dilutions	Flow Cyt 1:100
Formulation & Reconstitution	Liquid，PBS with 0.05% Proclin300, 1% BSA
Host Species	Homo sapiens
IgG type	IgG1
Reactivity	Human
Target	CTLA-4
Description	PE-conjugated Anti-CTLA-4 (ipilimumab biosimilar) mAb
Delivery	3-4 weeks
Storage & Shipping	Store at 2°C-8°C for 6 months
Background	Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Usage	Research use only；All DIMA recombinant antibodies are genuinely generated by DIMA Biotech. They are all under patent application. Any protein sequencing or reverse engineering attempt is prohibited. We are actively scrutinizing all patent application to ensure no IP infringement.
Conjugate	PE-conjugated